Article info

Download PDFPDF
Review
Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn’s disease: an overview and update

Authors

  1. Correspondence to Prof Jeremy Sanderson, IBD Centre, Guy's and Saint Thomas' NHS Foundation Trust, London SE1 7EH, UK; jeremy.sanderson{at}kcl.ac.uk
View Full Text

Citation

Honap S, Johnston E, Agrawal G, et al
Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn’s disease: an overview and update

Publication history

  • Received March 16, 2020
  • Revised May 28, 2020
  • Accepted June 14, 2020
  • First published July 28, 2020.
Online issue publication 
August 06, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.